| Financial Year |
March 31 2023 |
| Monetary Funds |
699,749,511.28 |
| Held-for-trading Financial Assets |
2,725,009,623.36 |
| Notes Receivable |
3,083,057.46 |
| Accounts Receivable |
554,522,506.96 |
| Advances to Suppliers |
24,462,372.31 |
| Other Receivables |
7,329,738.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
849,547,744.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
346,179,541.70 |
| Other Current Assets |
32,779,707.07 |
| Total Current Assets |
5,242,663,802.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
107,376,965.06 |
| Long-term Equity Investment |
-- |
| Investment Properties |
107,951,611.76 |
| Fixed Assetes |
729,353,077.08 |
| Under-construction Projects |
626,724,829.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,485,112.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
66,099,039.74 |
| Deferred Income Tax Assets |
25,716,076.50 |
| Other Non-Current Assets |
26,711,429.88 |
| Sub-Total of Non-Current Assets |
2,015,107,224.74 |
| Total Assets |
7,257,771,027.56 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
147,034,137.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,017,116.49 |
| Taxes Payable |
98,581,955.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
74,956,389.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,314,132.42 |
| Other Current Liabilities |
5,838,429.73 |
| Sub-Total of Current Liabilities |
468,436,928.04 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
28,174,865.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,733,186.24 |
| Total Liabilities |
503,170,114.28 |
| Paid-In Capital(Or Share Stock) |
786,126,335.00 |
| Capital Surplus |
1,348,259,321.99 |
| Surplus Reserve |
393,063,167.50 |
| LESS:Treasury Stock |
16,286,985.00 |
| Undistributed Profits |
4,229,413,029.62 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,754,600,913.28 |
| Owner's Equity（Stockholder's Equity） |
6,754,600,913.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,257,771,027.56 |
